HillSignal

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Total Raised
--
Contracts
--
Patents
--
PAC Giving
--

Government Contracts & Awards

No recent government contracts or awards found.

Proprietary Tech & Patents

No patents found in our USPTO sample (a narrow, keyword-clustered feed of recent grants in strategic tech sectors — not a comprehensive patent database).

Form D Funding

No recent SEC Form D filings found.

Market Intelligence & News

SeekingAlpha Aug 6, 2026

Pacific Biosciences of California, Inc. (PACB) Q2 2026 Earnings Call Transcript

Pacific Biosciences of California, Inc. (PACB) Q2 2026 Earnings Call August 5, 2026 4:30 PM EDTCompany ParticipantsChristian Henry - President, CEO &...

Benzinga Aug 5, 2026

Pacific Biosciences Of California Approves Restructuring Plan To Align With Strategic Initiatives; Restructuring To Reduce Workforce By About 8%; Expects $30M-$40M Annualized Operating Expense Reduction By End Of 2027; Estimates $2M Pre-Tax Charges For Reduction In Force

On July 30, 2026, the Board of Directors (the "Board") of the Company approved a restructuring plan to continue to better align the Company’s organizational structure and resources with its strategic

Benzinga Aug 5, 2026

Pacific Biosciences of California Appoints Mark Van Oene As President, CEO, Effective Immediately, Succeeding Christian Henry

Pacific Biosciences of California, Inc. (NASDAQ: PACB) ("PacBio"), a leading developer of high-quality, highly accurate sequencing solutions, today announced that its Board of Directors has appointed Mark Van

Yahoo Jun 16, 2026

Is Pacific Biosciences of California, Inc. (PACB) One of the Best Genomics Stocks to Buy According to Wall Street?

Pacific Biosciences of California, Inc. (NASDAQ:PACB) is one of the 8 Best Genomics Stocks to Buy According to Analysts. On May 26, Pacific Biosciences of California, Inc. (NASDAQ:PACB) began global shipments of its SPRQ-Nx sequencing chemistry and new multi-use SMRT Cells for the Revio platform. The firm lowered the per-genome list price to $345 and authorized […]

Congressional Trades in $PACB

No disclosed congressional trades found in $PACB.

Insider Trades (Form 4)

SELLSee Remarks

Van Oene Mark

$30,40926,911 shares Aug 19, 2026
GRANTSee Remarks

Van Oene Mark

489,130 shares Aug 11, 2026

Key People

Van Oene Mark

See Remarks

Insider

Political Giving

No disclosed PAC contributions found for this entity.

Factual Connections

Connections to other companies, executives, and politicians — sourced from disclosed trades, shared officers/directors, and public filings — are a Pro/Alpha feature.

Upgrade to Pro